Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

This communication comments on the three papers by the FDA CDER research team on the regulatory perspective of the missing data problem. The focus is on two topics: causal estimand and sensitivity analysis.

Original languageEnglish (US)
Pages (from-to)2880-2886
Number of pages7
JournalStatistics in Medicine
Volume35
Issue number17
DOIs
StatePublished - Jul 30 2016

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Statistics and Probability

Fingerprint

Dive into the research topics of 'Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem'. Together they form a unique fingerprint.

Cite this